机构：Since after the outbreak of COVID-19 happened in China, an increasingly more of confirmed cases and death cases have been reported. It is crucial to find a potential treatment for this epidemic. Based on the information provided by researchers, this virus is based on the RNA, cutting down the duplication of RNA can eventually inhibit the process of generating the protein, which is essential to the diffusion of virus. Fidaxomicin, a medicine that has a function to inhibit the polymerase in the process of transcription, which is one of those two processes of protein-generation. So, this medicine can theoretically inhibit the illness.
